Up to 2 years of treatment with lurasidone in youth presenting with bipolar depression was generally safe and well tolerated, with a relatively low rate of study discontinuation, minimal impact on weight, metabolic parameters, and prolactin, and long-term improvement in depressive symptoms. This evidence concerns the gene PRL and bipolar disorder.